933 related articles for article (PubMed ID: 33063674)
1. Role of Genetic Variants and Gene Expression in the Susceptibility and Severity of COVID-19.
Choudhary S; Sreenivasulu K; Mitra P; Misra S; Sharma P
Ann Lab Med; 2021 Mar; 41(2):129-138. PubMed ID: 33063674
[TBL] [Abstract][Full Text] [Related]
2. ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients.
Ravaioli S; Tebaldi M; Fonzi E; Angeli D; Mazza M; Nicolini F; Lucchesi A; Fanini F; Pirini F; Tumedei MM; Cerchione C; Viale P; Sambri V; Martinelli G; Bravaccini S
Cell Transplant; 2020; 29():963689720968749. PubMed ID: 33108902
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract.
Ortiz ME; Thurman A; Pezzulo AA; Leidinger MR; Klesney-Tait JA; Karp PH; Tan P; Wohlford-Lenane C; McCray PB; Meyerholz DK
EBioMedicine; 2020 Oct; 60():102976. PubMed ID: 32971472
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk.
Öztürk AB; Çağlayan B
Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):282-285. PubMed ID: 32914945
[No Abstract] [Full Text] [Related]
5. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.
Dong M; Zhang J; Ma X; Tan J; Chen L; Liu S; Xin Y; Zhuang L
Biomed Pharmacother; 2020 Nov; 131():110678. PubMed ID: 32861070
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics.
Gupta R; Charron J; Stenger CL; Painter J; Steward H; Cook TW; Faber W; Frisch A; Lind E; Bauss J; Li X; Sirpilla O; Soehnlen X; Underwood A; Hinds D; Morris M; Lamb N; Carcillo JA; Bupp C; Uhal BD; Rajasekaran S; Prokop JW
J Biol Chem; 2020 Aug; 295(33):11742-11753. PubMed ID: 32587094
[TBL] [Abstract][Full Text] [Related]
7. Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells.
Lee S; Yoon GY; Myoung J; Kim SJ; Ahn DG
Emerg Microbes Infect; 2020 Dec; 9(1):2169-2179. PubMed ID: 32969768
[TBL] [Abstract][Full Text] [Related]
8. Targeting TMPRSS2 in SARS-CoV-2 Infection.
Baughn LB; Sharma N; Elhaik E; Sekulic A; Bryce AH; Fonseca R
Mayo Clin Proc; 2020 Sep; 95(9):1989-1999. PubMed ID: 32861340
[TBL] [Abstract][Full Text] [Related]
9. Expression of SARS-CoV-2 receptor
Weatherbee BAT; Glover DM; Zernicka-Goetz M
Open Biol; 2020 Aug; 10(8):200162. PubMed ID: 32750256
[TBL] [Abstract][Full Text] [Related]
10. No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019.
Pan F; Xiao X; Guo J; Song Y; Li H; Patel DP; Spivak AM; Alukal JP; Zhang X; Xiong C; Li PS; Hotaling JM
Fertil Steril; 2020 Jun; 113(6):1135-1139. PubMed ID: 32482249
[TBL] [Abstract][Full Text] [Related]
11. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated.
Wambier CG; Goren A
J Am Acad Dermatol; 2020 Jul; 83(1):308-309. PubMed ID: 32283245
[TBL] [Abstract][Full Text] [Related]
12. Elevated FiO
Myti D; Gunjak M; Casado F; Khaghani Raziabad S; Nardiello C; Vadász I; Herold S; Pryhuber G; Seeger W; Morty RE
Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L670-L674. PubMed ID: 32878480
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2).
Guo X; Chen Z; Xia Y; Lin W; Li H
J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104
[TBL] [Abstract][Full Text] [Related]
14. Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19.
Wu C; Ye D; Mullick AE; Li Z; Danser AHJ; Daugherty A; Lu HS
Hypertension; 2020 Oct; 76(4):e29-e30. PubMed ID: 32673509
[No Abstract] [Full Text] [Related]
15. Myocyte-Specific Upregulation of
Tucker NR; Chaffin M; Bedi KC; Papangeli I; Akkad AD; Arduini A; Hayat S; Eraslan G; Muus C; Bhattacharyya RP; Stegmann CM; ; Margulies KB; Ellinor PT;
Circulation; 2020 Aug; 142(7):708-710. PubMed ID: 32795091
[TBL] [Abstract][Full Text] [Related]
16. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium.
Sajuthi SP; DeFord P; Li Y; Jackson ND; Montgomery MT; Everman JL; Rios CL; Pruesse E; Nolin JD; Plender EG; Wechsler ME; Mak ACY; Eng C; Salazar S; Medina V; Wohlford EM; Huntsman S; Nickerson DA; Germer S; Zody MC; Abecasis G; Kang HM; Rice KM; Kumar R; Oh S; Rodriguez-Santana J; Burchard EG; Seibold MA
Nat Commun; 2020 Oct; 11(1):5139. PubMed ID: 33046696
[TBL] [Abstract][Full Text] [Related]
17. Assessment of risk conferred by coding and regulatory variations of
Senapati S; Kumar S; Singh AK; Banerjee P; Bhagavatula S
J Genet; 2020; 99(1):. PubMed ID: 32661206
[TBL] [Abstract][Full Text] [Related]
18. Genetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19.
Gemmati D; Tisato V
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32899439
[TBL] [Abstract][Full Text] [Related]
19. Host Polymorphisms May Impact SARS-CoV-2 Infectivity.
Brest P; Refae S; Mograbi B; Hofman P; Milano G
Trends Genet; 2020 Nov; 36(11):813-815. PubMed ID: 32828550
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
